SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatements

Media Coverage
SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatements
No items found.

Outsourced Pharma covers the recent trade agreement with SHINE and Nucleus RadioPharma. Read the coverage below.

https://www.outsourcedpharma.com/doc/shine-technologies-and-nucleus-radiopharma-partner-to-advance-radioligand-cancer-treatments-0001

Lutetium-177 Information Sheet (EU Distribution)Ilumira Information Sheetdownload PDF RESOURCE HERE

Share This Story, Choose
Your Platform!

Share These Events,
Choose Your Platform!

Related Content
Latest news

Discover latest posts from the SHINE team.